Preventive Cardiovascular Nurses Association
PCNA Login
Preventing Cardiovascular Disease
through continuing education, clinical tools and national health initiatives.
The current state of healthcare demands that nurses play a leading role in cardiovascular risk reduction.
Late Breaking News RSS newsfeed
- Weight Loss Pill Meridia Raises Heart Attack, Stroke Risks - WebMD
- Another Maryland cardiologist in hot water over unnecessary procedures
- CURRENT-OASIS 7 published: Double-dose clopidogrel in PCI debated
- ESC guidelines give top recommendation to CRT for mild heart failure
- KYOTO and JIKEI HEART analyses show benefit of valsartan in Japanese hypertensive patients
- REALISE-AF registry: Much still to do in atrial fibrillation
- PACE: Dyssynchrony leads to lower ejection fraction in RVA-paced heart-failure patients
- Maryland mulls Midei case as cardiology orgs ask legislators to leave policing procedures to doctors
- Experts debate merits of DES for acute MI
- Pilot Testing of a Multicomponent Home Care Intervention for Older Adults With Heart Failure: An Academic Clinical Partnership
- Determinants of Global Perceived Health in Community-Dwelling Elderly Screened for Heart Failure and Sleep-Disordered Breathing
- Clinical Events in Coronary Heart Disease Patients With an Ejection Fraction of 40% or Less: 3-Year Follow-up Results
- Association Between Acute and Chronic Life Events on Acute Coronary Syndrome: A Case-Control Study
- Human Responses to Pulmonary Arterial Hypertension: Review of the Literature
- Predictors of Depressive Symptoms in Caregivers of Patients With Heart Failure
- Low Blood Pressure and Preserved Systolic Function in Elders With Heart Failure
- Determining Psychosocial Research Priorities for Adolescents With Implantable Cardioverter Defibrillators Using Delphi Methodology
- Cognitive Impairment Predicts Functional Capacity in Dementia-Free Patients With Cardiovascular Disease
- Do Cognitive Coping and Goal Adjustment Strategies Used Shortly After Myocardial Infarction Predict Depressive Outcomes 1 Year Later?
- Summaries of Nursing Care-Related Systematic Reviews From the Cochrane Library: Erythropoiesis-Stimulating Agents for Anemia in Chronic Heart Failure Patients
- Summaries of Nursing Care-Related Systematic Reviews From the Cochrane Library: Exercise-Based Rehabilitation for Coronary Heart Disease
- American Heart Association: Council on Cardiovascular Nursing
- Dietary Sodium Reduction: A Public Health Approach to Decreasing Hypertension
- PCNA Annual Scientific Meeting Abstracts
- PCNA: Preventive Cardiovascular Nurses Association
- Dual-chamber pacing beats single-chamber pacing for sick sinus syndrome in DANPACE
- ANTIPAF: ARB, on its own, doesn't suppress paroxysmal atrial fib
- Rivaroxaban almost superior to usual care in treatment of DVT
- Black race an independent predictor of stent thrombosis after DES placement
- AVERROES: Apixaban yields significant reductions in stroke, no increased bleeding
- FUTURA/OASIS-8: Standard-dose heparin recommended during PCI to avoid catheter thrombosis with fondaparinux
- CTT meta-analysis: No cancer risk with statins, low LDL-cholesterol levels
- Colchicine halves incidence of postpericardiotomy syndrome
- Four-year REACH analysis grasps a variety of clinical factors that flag atherothrombosis risk
- ATOLL seen as supporting enoxaparin over standard heparin in primary PCI
- ART: Early results for bilateral IMA in CABG offer some promises, some concerns
- New class of antiplatelet agents in clinical trials
- ISAR-REACT 3A: Lower heparin dose preferable in elective PCI
- INNOVATE PCI: Elinogrel, a new antiplatelet agent, passes initial hurdles
- LESSON I: Everolimus bests sirolimus in nonrandomized DES face-off
- Exercise can treat cardiovascular disease as well as prevent it
- New PLATO data: No need for gene testing in PCI patients
- STAR-heart study: Stem cells associated with improved long-term hemodynamics and reduced mortality in chronic heart failure
- EPO a no-go in post-MI patients: HEBE III
- PCI gains ground for left main and multivessel disease in new ESC revascularization guidelines
- PEARL-HF: New potassium-binding resin reduces hyperkalemia in heart failure
- RE-LY INR analysis confirms dabigatran benefits across spectrum of warfarin dosing
- CURE ACTIVE: No effect of loss-of-function clopidogrel gene on event rates in ACS or AF
- SHIFT: Adding HR-slowing agent ivabradine to HF meds cuts mortality, hospitalization
- Alpha Omega Trial: n-3 fatty acids fail to reduce cardiovascular events in post-MI patients
- FDA approves aliskiren/amlodipine combo for hypertension
- Judge declines to stop sales of generic Lovenox; cites lower cost
- Who's the boss? White House recommends physicians join hospitals, large groups
- Drs George Dangas and Roxana Mehran leave Columbia for Mount Sinai
- Migraine with aura linked to increased mortality from stroke and heart disease
- Pill pickle: Hypotension drug quandary spotlights tough FDA's dilemma
- Meta-analysis shows newer P2Y12 inhibitors decrease mortality after PCI compared with clopidogrel
- Merck sues generic drugmaker over Vytorin patent infringement
- Three-million patient study yields new AAA risk-score system
- Rosiglitazone, pioglitazone pose similar CV risk in case-matched analysis
- Routine balloon pump unnecessary for high-risk/low-EF PCI patients: BCIS-1
- JUPITER: Statin therapy effective in intermediate-risk, high-CRP patients
- Medicare agency proposes new VAD policy
- AHA issues call to action on CVD research in Asian Americans
- What's going to be hot at ESC 2010 Congress
- Pericardial fat is an independent predictor of AF
- Atrial fibrillation? Don't blame caffeine, says Women's Health Study
- ASIR technique reduces radiation from CT angiography
- Binge drinking heightens death risk in those with high blood pressure
- Same-day discharge possible in elective, uncomplicated PCI
- Piedmont gains VAD, transplant specialist David Dean
- New troponin recommendations should bridge gap between lab and clinic
- Early chronic kidney disease associated with atrial fibrillation
- Amphetamine abuse tied to aortic dissection in observational study
- Drugmaker: Midodrine withdrawal plans predated FDA's
- Cholesterol levels vary throughout the menstrual cycle
- Gold nanoparticles swarm vulnerable plaque
- Sponge fails to prevent sternal-wound infections
- Experts debate value of measuring renin levels to guide hypertension therapy
- Bariatric surgery slashes medications, costs in diabetics
- "Troubling" drop in outpatient use of HF meds
- Cath labs should use both CoreValve and Sapien, small study concludes
- Reducing healthcare system delay may be key to improving STEMI survival
- Allowing patients to refuse VAD support is ethical, Mayo review concludes
- Higher exercise capacity equals improved survival in older adults
- Sleeping too much or too little linked to higher CV risk
- Excuses for eating chocolate can now include heart-failure prevention
- Switching protein sources may reduce CHD risk
- FDA recommends withdrawal of midodrine
- Antagonistic people have thicker carotid walls, increased CVD risk
- Mortality-TLR link poststenting probed in five-year SIRIUS analysis
- The "MacStatin": Fast food with some ketchup, salt, and a statin to go
- No MI, mortality threat from echo contrast agents in meta-analysis
- One in four stroke patients stops taking meds within months
- CRESCENDO, rimonabant's "obituary," published in Lancet
- Two-part reversible anticoagulant performs well with PCI in small trial
- Chocolate for blood pressure too hard to stomach, researchers say
- Birth weight a clue to later risk of atrial fibrillation in WHS cohort
- Platelet assay betters clopidogrel gene testing: Study published
- JETSTENT published: Mechanical thrombectomy before PCI disputed
- Kandzari leaves Scripps for Piedmont Heart Institute
- Fibrosis in hypertrophic cardiomyopathy: Chicken or the egg?
- Temperature drops lead to more MIs
- Arizona Heart Hospital bought for $32 million
- FDA warns of migration and embolization with inferior vena cava filters, as new fracture data published
- Telemonitoring of HF patients reduces deaths, costs
- SHAPE group proposes update to CAC, CIMT screening "guidelines" in time for AHA
- Sibutramine CV safety, lorcaserin, up for FDA review
- History of gout linked to HF risk; allopurinol attenuates this
- Coronary calcium controversy continues
- RICH and PRINCE probe prehospital therapeutic hypothermia after cardiac arrest
- High-dose clopidogrel given in the cath lab equivalent to preloading
- B vitamins fail to prevent secondary major vascular events: Final VITATOPS results published
- UK stroke/TIA patients not getting timely surgery
- Similar weight loss, HDL edge for low-carb vs low-fat in randomized diet study
- Mipomersen passes hurdle in two trials
- FDA recommends changes to 510(k) process
- New loci for blood lipids identified; functional role of 1p13 locus detailed
- EINSTEIN-DVT: Rivaroxaban meets primary end point in VTE trial
- Amid mounting debts, physician-owned Arizona Heart Institute files for bankruptcy as part of acquisition deal
- Declining cardiac function accelerates brain aging
- Wide variation in rates of carotid endarterectomy and stenting throughout US
- Calcium supplements boost heart-attack risk: Meta-analysis
- Mechanical-valve pioneer, philanthropist Donald Shiley dead at 90
- FDA warns against IV administration of nimodipine
- Early cholesterol predicts later coronary calcium
- Transradial PCI approach reduces bleeding, MACE in STEMI patients
- COR-I: Combo drug leads to significant weight loss, but CV effects questioned
- Sanofi-Aventis sues FDA over generic Lovenox approval
- Advisory panel votes to recommend FDA approval of ticagrelor
- Two new randomized trials bolster benefits of compression-only CPR
- Traditional tools for gauging neurological prognosis post-cardiac arrest may no longer be accurate: Study
- Taking patients directly to existing PCI centers is more cost-effective than expanding PCI capacity
- Dr Terry Ferguson moves on to AstraZeneca
- Arguments continue over the metabolic syndrome
- Avoiding lowest-volume centers and adhering to quality measures lower cost of CABG overall
- Researchers make myocytes to mimic long-QT syndrome
- Acute-MI care at "high-quality" hospitals as likely for blacks, whites: Medicare data
- FDA advisors to contemplate PLATO at July 28 meeting on ticagrelor
- FDA approves another triple-drug combination for resistant hypertension: Tribenzor
- Does drinking alcohol temporarily heighten stroke risk?
- FDA approves first generic enoxaparin injection
- Unique study reveals "mosaic" model for triglyceride genetics
- HF symptom variability more prognostic than severity?
- Boston Scientific safety alert on older ICD models
- Patients with diabetes have alternatives to rosiglitazone, experts say
- Half of young adults have CHD risk factors
- Therapeutic window identified for clopidogrel?
- More from JUPITER: HDL not predictive of risk at very low LDL levels
- FDA stops enrollment in TIDE trial
- Trans fat use "close to zero" in fast-food chains
- Hope on the horizon for better antidiabetic drugs
- News report links Avandia panelists to drug makers
- New document lays out key competencies needed to manage advanced heart failure and transplant
- NICE issues final guidance on dronedarone
- Most patients with CVD can fly safely, says British Cardiovascular Society
- Healthy weight, rather than fitness, most important for preventing high blood pressure
- Disparities in DES use demonstrated in "real-world" study
- Triglyceride and waist measurements predict heart-disease risk
- Depression and erectile dysfunction are independent risk factors for heart disease
- Class 4 angina more likely associated with severe CAD in women than men
- FDA to look into possible cancer risk with ARBs
- Conflicted FDA committee votes against recommending approval of weight-loss drug Qnexa
- New guideline advocates MRI over CT for stroke diagnosis
- Obstructive sleep apnea underestimated in AF patients
- Former VP Cheney gets an LVAD
- Rosiglitazone meeting: Advisory committee delivers mixed message to FDA
- Chronic total occlusion PCI may reduce mortality, but randomized trial is still at least a year away
- Selective cholesterol screening missing kids who qualify for drug therapy
- Significant weight loss in obese and overweight patients treated with lorcaserin
- Sleep apnea linked to heart failure in men, but not women
- Heart-healthy lifestyle change usually requires combinations of cognitive approaches
- Day one: Data deluge at FDA rosiglitazone review provides more questions than answers
- More evidence against GSK and FDA on rosiglitazone
- New SNP associated with range of major vascular diseases
- Other PFO/stroke trials will continue
- Sudden cardiac death risk stratification with SPECT shows promise in observational study
- No letup for GSK: EMA set to review rosiglitazone
- Heart and Soul: More evidence linking anxiety and coronary heart disease
- More data linking cardiac imaging to high radiation exposure
- You've got mail! Patient-doctor email helps achievement of CV treatment goals
- As rosiglitazone review looms, FDA documents slam RECORD and find significant risks for the drug
- "Encouraging results" with endovascular repair of ruptured thoracic-aortic aneurysm
- Dyspnea with ticagrelor is "common, but mild and self-limiting"
- Acquired von Willebrand syndrome exacerbates bleeding risk in VAD recipients
- ADVANCE: Severe hypoglycemia a marker, not cause, of poor diabetes outcomes?
- Hospital MI mortality rates declining: CMS
- Self-titration of antihypertensive therapy boosts BP control
- INVEST blood-pressure study published: Benefit of tight control on CV outcomes questioned
- Most patients willing to wear defibrillator on the outside
- Allopurinol regresses left ventricular hypertrophy in chronic kidney disease
- Women receive fewer appropriate ICD interventions in primary prevention of sudden death
- New ONTARGET analysis: Monitor albuminuria to predict CV risk, death
- MedPAC floats a variety of options for reforming imaging self-referral rules
- New meta-analysis: CYP2C19*2 carriers at higher risks of events on clopidogrel
- Cardiologists don't ask about nutraceutical/OTC meds
- Class I recall for LIFEPAK 20, 20e defibrillator/monitors
- PLANET I and II: Atorvastatin beats rosuvastatin for protecting kidneys in diabetic and nondiabetic patients
- Journal Scan: White Rice, Brown Rice, and Risk of Type 2 Diabetes in US Men and Women (Arch Intern Med 2010;170:961-969.)
- Journal Scan: Surgical Management of Descending Thoracic Aortic Disease: Open and Endovascular Approaches. A Scientific Statement From the American Heart Association (Circulation 2010;121:2780-2804.)
- Clinical Trial Summary: A Comparison of Outcomes in Patients in New York Heart Association Class II Heart Failure When Treated With Eplerenone or Placebo in Addition to Standard Heart Failure Medicines (EMPHASIS-HF)
- Case Study: A 51-Year-Old Man Presents With Inability to Achieve Weight Loss, Exercise Intolerance, and Elevated Blood Sugars
- Expert Opinion: Relevance of statin pleiotropism to cardiovascular outcomes after ACS
Annual Symposium indexPCNA 3-day April Program on Cardiovascular Risk Reduction
PCNA 17th Annual Symposium - Orlando, FL
March 10-12, 2011